Cytokine storms, evolution and COVID-19-Reference-Cited by-同舟云学术

Cytokine storms, evolution and COVID-19

Published:2021-01-01 Issue:1 Volume:9 Page:83-92
ISSN:2050-6201
Container-title:Evolution, Medicine, and Public Health
language:en
Short-container-title:

Author:

Alcock Joe¹^ORCID,Masters Alix²

Affiliation:

1. Department of Emergency Medicine, MSC11 6025 1, University of New Mexico, Albuquerque, NM 87131, USA

2. Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA

Abstract

Lay Summary Many treatments for COVID-19 are aimed at calming a cytokine storm, a dangerous immune overreaction to the infection. Treating cytokine storms has been tried for decades in sepsis and other viral illnesses, but these treatments most often do not work. We explain why cytokine storms should be rare, and what special evolutionary circumstances can cause them to occur.

Publisher

Oxford University Press (OUP)

Subject

Health, Toxicology and Mutagenesis,Ecology, Evolution, Behavior and Systematics,Medicine (miscellaneous)

Link

http://academic.oup.com/emph/advance-article-pdf/doi/10.1093/emph/eoab005/36195482/eoab005.pdf

Reference88 articles.

1. Inflammatory and humoral immune response during Ebola virus infection in survivor and fatal cases occurred in Sierra Leone during the 2014–2016 outbreak in West Africa;Colavita;Viruses,2019

2. Host response to influenza virus: protection versus immunopathology;Peiris;Curr Opin Immunol,2010

3. COVID-19: consider cytokine storm syndromes and immunosuppression;Mehta;Lancet,2020

4. Into the eye of the cytokine storm;Tisoncik;Microbiol Mol Biol Rev MMBR,2012

5. A question of self-preservation: immunopathology in influenza virus infection;Gruta;Immunol Cell Biol,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage‐Mimicking Cellular Nanoparticles Scavenge Proinflammatory Cytokines in Specimens of Patients with Inflammatory Disorders;Advanced Science;2024-06-17

2. Autopsy findings in cancer patients infected with SARS-CoV-2 show a milder presentation of COVID-19 compared to non-cancer patients;GeroScience;2024-04-30

3. COVID-19 and the Interplay With Antibacterial Drug Resistance;Advances in Medical Diagnosis, Treatment, and Care;2024-03-15

4. Integrating microbiome science and evolutionary medicine into animal health and conservation;Biological Reviews;2023-11-13

5. What have we learned from a case of convalescent plasma treatment in a two-time kidney transplant recipient COVID-19 patient? A case report from the perspective of viral load evolution and immune response;Frontiers in Nephrology;2023-06-23